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ABSTRACT 
Microtubule-associated protein 1 light chain 3 
alpha (LC3)/GABA type A receptor–associated 
protein (GABARAP) comprises a family of 
ubiquitin-like proteins involved in 
(macro)autophagy, an important intracellular 
degradation pathway that delivers cytoplasmic 
material to lysosomes via double-membrane 
vesicles called autophagosomes. The only 
currently known cellular molecules covalently 
modified by LC3/GABARAP are membrane 
phospholipids such as phosphatidylethanolamine 
in the autophagosome membrane. Autophagy-
related 4A cysteine peptidase (ATG4) proteases 
process inactive pro-LC3/GABARAP before 
lipidation, and the same proteases can also 
deconjugate LC3/GABARAP from lipids. To 
determine whether LC3/GABARAP has other 
molecular targets, here we generated a 
preprocessed LC3B mutant (Q116P) that is 
resistant to ATG4-mediated deconjugation. Upon 
expression in human cells and when assessed by 
immunoblotting under reducing and denaturing 
conditions, deconjugation-resistant LC3B 
accumulated in multiple forms and at much higher 
molecular weights than free LC3B. We observed a 
similar accumulation when preprocessed versions 
of all mammalian LC3/GABARAP isoforms were 
expressed in ATG4-deficient cell lines, suggesting 
that LC3/GABARAP can attach also to other 
larger molecules. We identified ATG3, the E2-like 
enzyme involved in LC3/GABARAP lipidation, as 
one target of conjugation with multiple copies of 
LC3/GABARAP. We show that LC3B–ATG3 
conjugates are distinct from the LC3B–ATG3 
thioester intermediate formed before lipidation, 
and we biochemically demonstrate that ATG4B 
can cleave LC3B–ATG3 conjugates. Finally, we 
determined ATG3 residue K243 as an LC3B 
modification site. Overall, we provide the first 
cellular evidence that mammalian 
LC3/GABARAP post-translationally modifies 
proteins akin to ubiquitination (‘LC3ylation’), 
with ATG4 proteases acting like deubiquitinating 
enzymes to counteract this modification 
(‘deLC3ylation’). 
 
 
Introduction 
Protein degradation in eukaryotic cells occurs via 
two main pathways: macroautophagy (hereafter 
autophagy) and the ubiquitin-proteasome system 
(UPS). Autophagy involves the trafficking of bulk 
cytoplasmic material to lysosomes via 
autophagosomes (double-membrane bound 
organelles) (1), and can degrade entire organelles, 
protein aggregates and long-lived proteins. In 
contrast, the UPS targets individual polypeptides 
for proteolysis as signaled by the small protein 
ubiquitin (2). Ubiquitin becomes covalently 
attached via its carboxyl terminus to the lysine or 
amino group of target proteins, forming a stable 
amide linkage and acting as a post-translational 
modification. This reaction occurs via ATP-
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dependent activation of ubiquitin by E1 activating 
enzymes (3), followed by the action of E2 
conjugating enzymes and E3 ligase components 
(4). The attachment of polyubiquitin chains linked 
via their K48 residues is the canonical signal for 
proteasome-mediated degradation of the target 
protein, while other types of ubiquitination 
modification exist that can have multiple cellular 
consequences (5). Ubiquitination is reversed by 
deubiquitinating enzymes (DUBs), a set of 
cysteine proteases and metalloproteases that can 
cleave the amide bond between ubiquitin and its 
targets (6). 
Autophagy is regulated by two consecutive 
ubiquitin-like conjugation reactions that closely 
resemble ubiquitination, both in terms of their 
biochemical mechanism and involvement of 
proteins that bear the ubiquitin beta-grasp fold 
within their tertiary structure (7). The first is the 
ATG12-ATG5 conjugation system, in which the 
ubiquitin-like protein ATG12 is covalently 
attached to ATG5 by E1-like ATG7 and E2-like 
ATG10 (8, 9). The stable ATG12-ATG5 conjugate 
associates with ATG16L1 protein, forming a 
multimeric complex that localizes to the outer 
membrane of forming autophagosomes and 
dissociates prior to their closure (10–12). The 
second ubiquitin-like reaction is the LC3-PE 
conjugation system, involving covalent attachment 
of small (approx. 13-17 kDa) ubiquitin-like 
LC3/GABARAP proteins (ATG8 in yeast) to 
phospholipids on the autophagosome membrane 
such as phosphatidylethanolamine (PE) (13–15). 
This reaction known as LC3 lipidation is mediated 
by the same E1-like enzyme (ATG7), a distinct 
E2-like enzyme (ATG3), and enhanced in an E3-
like manner by the ATG12-ATG5 conjugate (13, 
16–18). LC3 lipidation functions in several aspects 
of autophagy including membrane expansion, 
cargo recruitment, and autophagosome-lysosome 
fusion (19–24).  
Unlike ATG12-ATG5 conjugation, 
LC3/GABARAP lipidation can be reversed by the 
DUB-like cysteine protease ATG4 in a reaction 
known as delipidation or deconjugation (25, 26). 
ATG4 also performs an upstream processing event 
known as LC3/GABARAP priming, in which a C-
terminal extension of one or more amino acid 
residues is rapidly removed from newly-
synthesized pro-LC3/GABARAP through 
proteolysis (14, 25, 26). This step is essential for 
subsequent lipidation since it exposes the C-
terminus of the active glycine residue in 
LC3/GABARAP that later becomes attached to PE 
via an amide bond (13, 25). 
In humans, there are at least seven isoforms of 
LC3/GABARAP divided into the LC3 subfamily 
(MAP1LC3A, B, B2 and C) and GABARAP 
subfamily (GABARAP, -L1 and -L2) (16, 27–31), 
of which LC3B is the most studied and widely 
utilized as a marker for autophagosomes in 
mammalian cells. Lipidated LC3B localizes to 
autophagosomes during their formation and 
remains associated following autophagosome-
lysosome fusion, eventually being degraded or 
recycled (14, 32). The conversion of primed LC3B 
(LC3B-I) to the lipidated form (LC3B-II) can also 
be monitored by western blotting since the 
lipidated form is more negatively charged and thus 
migrates slightly faster in SDS-PAGE (14, 33). 
Four mammalian ATG4 proteases (ATG4A, B, C 
and D) process the LC3/GABARAP isoforms with 
partially overlapping redundancies, with ATG4B 
being the functionally dominant isoform in 
autophagy and essential for priming LC3B (34–
38). 
While ubiquitin is reported to attach to thousands 
of cellular target proteins (39), the only known 
target molecules of LC3/GABARAP conjugation 
are phospholipids including PE and possibly also 
phosphatidylserine (PS) (13, 15, 40). Considering 
LC3/GABARAP conjugation closely resembles 
ubiquitination and ATG4 is DUB-like, we decided 
to investigate whether other cellular targets might 
exist that can be modified with LC3/GABARAPs 
(‘LC3ylation’) and deconjugated by ATG4 
(‘deLC3ylation’). 
 
Results 
Deconjugation-resistant LC3B reveals presence 
of high molecular weight LC3B conjugates in 
cells 
As a tool to identify potential novel 
LC3/GABARAP conjugation targets, we decided 
to develop a deconjugation-resistant form of LC3B 
that could be expressed in mammalian cells. We 
sought to identify a mutation in LC3B that renders 
it resistant to processing by ATG4 proteases, but 
does not abolish conjugation when introduced into 
a pre-primed form of LC3B (LC3B G120). In the 
literature, we identified F80A+L82A double 
mutant (41) and F119A (42) as mutations in LC3B 
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known to impair cleavage by mammalian ATG4 
proteases, although the effects of these mutations 
on lipidation are unknown. Since LC3B is 
structurally ubiquitin-like and studies have shown 
that ubiquitin and SUMO can be rendered resistant 
to deconjugation by mutating a residue near their 
protease cleavage site to proline (43, 44), we also 
decided to generate two candidate equivalent 
LC3B mutations (Q116P and E117P). We 
introduced each of these mutations into a synthetic 
priming sensor construct consisting of full-length 
LC3B tagged at the C-terminus with GFP and N-
terminus with 3xFLAG. Expression of these 
constructs allowed us to compare the effect of 
each mutation on processing by endogenous 
ATG4 proteases in human HeLa cells. As seen in 
Fig. 1A, all tested mutations impeded ATG4-
mediated processing to varying degrees compared 
to WT LC3B, based on an increase in the level of 
unprocessed 3xFLAG-LC3B-GFP and a reduction 
in the level of processed 3xFLAG-LC3B. The 
Q116P mutation in particular led to the most 
robust reduction in processing, comparable to 
negative control G120A mutant that cannot be 
primed or lipidated (14).  
To test whether the LC3B mutations were 
compatible with PE conjugation, we introduced 
them into pre-primed GFP-LC3B G120 that 
localizes to distinct cytoplasmic puncta 
corresponding to autophagosomes upon lipidation 
(15). We expressed these constructs in human 
HAP1 cells and monitored localization following 
co-treatment with the mTOR inhibitor Torin1 (45) 
and lysosomal inhibitor bafilomycin A1 (baf A1) 
to induce autophagosome accumulation. As seen 
in Fig. 1B, the LC3B mutants F80A+L82A and 
F119A showed a defect in autophagosome 
localization similar to G120A, suggesting these 
mutations impaired lipid conjugation. In contrast, 
Q116P and E117P could localize to puncta in 
response to treatment, similar to LC3B WT and 
G120, suggesting these mutations are compatible 
with conjugation. Overall, the Q116P mutation 
best fit the criteria of impairing ATG4-mediated 
processing while permitting conjugation, making it 
suitable for generating a deconjugation-resistant 
LC3B mutant. Using the published LC3B-ATG4B 
co-crystal structure (42), we determined that the 
side chain of LC3B residue Q116 forms three 
hydrogen bonds with the backbone of ATG4B (at 
residue positions I317, N146 and L228) which are 
lost in LC3B Q116P mutant, suggesting these 
interactions are important for ATG4B-mediated 
processing (Fig. 1C). 
To determine the effect of impaired LC3B 
deconjugation in cells, we expressed 3x-FLAG 
tagged deconjugation-resistant LC3B Q116P G120 
in wild-type HeLa cells, with specific detection by 
western blotting using an anti-FLAG antibody. As 
seen in Fig. 1D, LC3B Q116P G120 could be 
converted to the -II form similar to LC3B WT and 
G120. In contrast, LC3B G120A was expressed as 
a single band corresponding to the pro- form (46). 
Strikingly, at much higher molecular weights than 
LC3B-I and LC3B-II, we could observe the 
presence of multiple bands that were specifically 
enriched in cells expressing deconjugation-
resistant LC3B Q116P G120. These bands ranged 
from an apparent molecular weight of 
approximately 60 kDa to over 180 kDa, and were 
not affected by autophagy induced by serum and 
amino acid starvation (Fig. S1A) or 
pharmacological treatments (Fig. S1B). Since 
western blotting was performed under reducing 
and denaturing conditions, the additional bands are 
unlikely to represent non-covalent and redox-
sensitive protein interactions with LC3B (47). 
Therefore our data indicates that LC3B can 
covalently conjugate to other unknown molecules 
in the cell that would normally be substrates of 
ATG4-mediated deconjugation. 
 
ATG4 proteases are responsible for 
counteracting LC3/GABARAP conjugate 
formation in cells 
To distinguish whether high molecular weight 
LC3B conjugates accumulated in cells due to loss 
of ATG4-mediated deconjugation rather than a 
secondary effect of Q116P mutation, we assessed 
whether genetic deficiency of ATG4 proteases 
induced conjugate accumulation. We also sought 
to determine whether other mammalian 
LC3/GABARAP isoforms had ability to form 
conjugates. Using wild-type HeLa cells versus 
those lacking ATG4B or ATG4A and ATG4B, we 
expressed LC3B G120 and the equivalent pre-
primed form of the other five conserved 
LC3/GABARAP isoforms (LC3A, LC3C, 
GABARAP, GABARAPL1 and GABARAPL2), 
alongside LC3B Q116P G120 as a positive control 
and LC3B G120A as a negative control (Fig. 2A). 
We found that indeed, expression of LC3B G120 
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in ATG4B KO cells resulted in the accumulation of 
conjugates with a strikingly similar pattern to the 
Q116P G120 mutant, suggesting that LC3B 
conjugates accumulate as a result of impaired 
ATG4B-mediated deconjugation. The lack of 
conjugate formation for LC3B G120A 
demonstrates that priming and thus C-terminal 
G120 exposure is required for conjugate 
formation. We found that conjugates of pre-
primed LC3A and LC3C also accumulated when 
expressed in ATG4B deficient cells, consistent 
with ATG4B being the main ATG4 isoform 
involved in LC3 subfamily processing (37). Some 
putative conjugates were faintly visible in control 
HeLa cells, particularly upon expression of pre-
primed 3xFLAG-LC3C, raising the possibility that 
LC3/GABARAP conjugates may exist at a 
reduced level under more physiological conditions 
when ATG4 is expressed. Pre-primed GABARAP 
subfamily proteins were relatively poor at forming 
conjugates when expressed in ATG4B KO cells. 
Remarkably, we could observe dramatic 
GABARAP subfamily conjugate accumulation in 
cells lacking both ATG4A and ATG4B, 
suggesting that ATG4A is involved in 
counteracting the formation of GABARAP 
subfamily conjugates and consistent with the 
known ability of ATG4A to prime GABARAP 
subfamily proteins (35, 37). Interestingly, all 
tested LC3/GABARAP isoforms could form 
conjugates in this cell model with a very similar 
band pattern, suggesting they likely modify the 
same target molecules (Fig. 2A). 
Next, we determined whether LC3/GABARAP 
conjugates were direct substrates of ATG4. We 
treated lysates from ATG4B KO cells expressing 
pre-primed LC3B G120 and deconjugation-
resistant LC3B Q116P G120 with purified 
recombinant GST-tagged ATG4B or catalytic 
inactive mutant C74S as a negative control (Fig. 
2B). This revealed that 3xFLAG-LC3B G120 
conjugates were indeed biochemical substrates of 
ATG4B, since their detection was lost upon 
treatment with active ATG4B WT but not inactive 
ATG4B C74S. As an internal positive control, 
lipidated 3xFLAG-LC3B G120 was efficiently 
cleaved by recombinant ATG4B WT. This 
experiment also demonstrated that 3xFLAG-LC3B 
Q116P G120 conjugates and the corresponding 
lipidated form were resistant to ATGB activity in 
vitro. Overall, these results confirm the enzymatic 
role of ATG4 proteases in counteracting 
LC3/GABARAP conjugate formation in cells. 
 
LC3B conjugates in ATG4B KO cells are not 
autophagy substrates 
Considering LC3B has a well-established role in 
autophagy, we decided to investigate whether 
LC3B conjugates were also affected by treatments 
that modulate LC3B lipidation and autophagy. As 
seen in Fig. 2C, we could observe GFP-LC3B 
conjugate accumulation in HeLa ATG4B KO cells 
stably expressing GFP-LC3B G120. We noted that 
the overall level of GFP-LC3B conjugates in 
ATG4B KO cells appeared unaffected by 
autophagy modulating treatments (Fig. 2C), 
consistent with our results for Q116P conjugates 
(Fig S1). This suggests that GFP-LC3B conjugates 
accumulate stably in the absence of ATG4B-
mediated deconjugation and are not degraded by 
autophagy, especially considering that autophagy 
is known to be functional in ATG4B KO cells 
rescued with GFP-LC3B G120 (38). We could 
also observe the formation of GFP-LC3B G120 
conjugates in ATG4A/B DKO cells when 
expressed at levels close to that of endogenous 
LC3B, ruling out the possibility that 
LC3/GABARAP conjugates are an overexpression 
artefact (Fig. S2).  
Next, in a cell fractionation and protease 
protection experiment we observed that 3xFLAG-
LC3B G120 could form conjugates when 
expressed in HAP1 ATG4B KO cells, 
demonstrating that this phenomenon is not 
restricted to a single cell model (Fig. 2D). The 
conjugates were observed to be present in the 
soluble fraction but absent from the membrane 
fraction enriched in 3xFLAG-LC3B-II, suggesting 
that they were not lipidated. Further, 3xFLAG-
LC3B conjugates were not protected from 
digestion by purified recombinant GST-ATG4B in 
the absence of detergent, suggesting they were not 
located within sealed membrane organelles such as 
autophagosomes. 
 
ATG3 is a protein target of LC3/GABARAP 
conjugation and ATG4-mediated deconjugation 
We took a candidate-based approach to identify 
novel targets of LC3B conjugation, prioritizing 
reported LC3B interacting proteins (48) that are 
predicted to be soluble, cytoplasmic and not 
known to be degraded by autophagy. We also 
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considered the minimum molecular weight of 
LC3B targets observed by western blotting, which 
we predicted to be approximately 35 kDa after 
accounting for the mass of tagged LC3B (Fig. 
2D). The strongest candidate based on these 
criteria was ATG3, the soluble cytoplasmic E2-
like conjugating enzyme component of the 
LC3/GABARAP lipidation reaction, which has a 
predicted molecular weight of 35.8 kDa (17, 49). 
To determine if ATG3 is a target of LC3B 
conjugation, we enriched 3xFLAG-LC3B G120 
conjugates from HeLa control and ATG4B KO 
cells by immunoprecipitation (IP) (Fig. 3A). 
Blotting with anti-FLAG antibody confirmed the 
enrichment of 3xFLAG-LC3B G120 and 
conjugates in the IP versus input lysates. We 
probed the same samples with two different 
antibodies targeting different portions of 
endogenous ATG3 (C-terminus and N-terminus, 
respectively). In addition to full-length ATG3, 
both antibodies specifically detected a number of 
high molecular weight conjugate bands likely 
corresponding to 3xFLAG-LC3B-ATG3 (Fig. 
3A). We then digested 3xFLAG-LC3B conjugates 
enriched from ATG4B KO cells by IP prior to 
blotting for FLAG and ATG3. As seen in Fig. 3B, 
high molecular weight bands detected using ATG3 
antibody were specifically lost upon digestion with 
active GST-ATG4B, confirming their identity as 
3xFLAG-LC3B conjugated to ATG3.  
It is well established that ATG3 forms a thioester-
linked covalent intermediate with the C-terminus 
of LC3/GABARAP during the PE conjugation 
reaction in wild-type cells (17), but this species 
can only be detected in lysates under non-reducing 
conditions (47). By comparing the same lysates 
prepared under non-reducing and reducing 
conditions, we confirmed that 3xFLAG-LC3B-
ATG3 and conjugates formed by deconjugation-
resistant LC3B or pre-primed LC3B in HeLa 
ATG4B KO cells are extremely stable under 
reducing conditions, making them distinguishable 
from the thioester-linked species in wild-type cells 
that are fully resolved under reducing conditions 
(Fig. 3C). 
Finally, we tested lysine residues by mutagenesis 
to identify a target residue of LC3B modification 
on ATG3. We specifically reconstituted the 
modification of transiently-expressed 3xFLAG-
ATG3 in HeLa ATG4B KO cells stably expressing 
GFP-LC3B G120 (Fig. S3A). We found that 
ATG3 activity was important, since catalytic-
inactive ATG3 C264A could not be efficiently 
modified (Fig. S3A). We therefore generated 
HeLa ATG3 KO cells using CRISPR-Cas9 
(validated by western blotting in Fig. S3B) to test 
in parallel the function of putative 3xFLAG-ATG3 
modification site mutants in restoring endogenous 
LC3B lipidation. This could help to rule out 
inactivity being the reason for loss of LC3B 
conjugation. We then generated 3xFLAG-ATG3 
constructs in which all or different sets of lysine 
residues were mutated to arginine (Fig. S3C). The 
first 13 lysine residues in ATG3 were important 
for efficient ATG3 expression but dispensable for 
LC3B lipidation (Fig. S3D and S3E). In contrast, 
ATG3 lacking the last 9 lysines could not rescue 
LC3B lipidation nor be efficiently modified by 
LC3B (Fig. S3D), despite expressing well and 
forming a thioester with endogenous 
LC3/GABARAP (Fig. S3E). We therefore tested 
single mutants of the last 9 ATG3 lysine residues, 
uncovering K243 as specifically required for 
efficient GFP-LC3B modification but not ATG3 
function, suggesting K243 is a major site of 
covalent LC3B modification (Fig. 3D). 
Interestingly, we also found that K295 was 
uniquely required for LC3B lipidation but not 
conjugate or thioester formation. 
In conclusion, our study demonstrates that human 
ATG4 proteases function as ‘deLC3ylation’ 
enzymes by counteracting the covalent attachment 
of LC3/GABARAP to other proteins in the cell 
such as residue K243 of ATG3 (Fig. 3E). 
   
Discussion 
Ubiquitin modifications play a major role in 
specifying protein fate and function, whereas 
LC3/GABARAP proteins have previously been 
believed to exclusively modify phospholipids to 
facilitate autophagy. We now demonstrate that 
LC3/GABARAP can modify other proteins, 
expanding our knowledge of the repertoire of post-
translational modifications that mammalian cells 
can potentially utilize to modulate protein 
function. We also show that the proteases ATG4A 
and ATG4B have a novel deconjugation function, 
acting as DUB-like enzymes to reverse 
LC3/GABARAP protein modifications. It proved 
necessary to use cellular models in which ATG4 
deconjugation activity is impaired to facilitate the 
discovery and characterization of LC3/GABARAP 
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protein conjugates. Therefore, we speculate that 
the abundance of these protein conjugates is 
normally limited by ATG4 activity in the 
cytoplasm. Any scenarios in which ATG4 activity 
is modulated could potentially affect the level of 
LC3/GABARAP protein conjugates, although this 
requires further study. For example, ATG4 
proteases are subject to regulation by post-
translational modifications such as oxidation (50) 
and phosphorylation (51–53). These modifications 
are proposed to provide mechanisms for 
spatiotemporal control of ATG4 activity, and 
could therefore be candidates for controlling the 
level of LC3/GABARAP protein conjugates in 
cells. 
We found that one major site of conjugation by 
LC3B on ATG3 is K243. ATG12 conjugation to 
ATG3 also occurs at K243, catalyzed by ATG3 
itself (54). LC3B-ATG3 modification may 
represent a similar autoconjugation mechanism 
due to its requirement for ATG3 activity. ATG12-
ATG3 conjugate is linked to mitochondrial 
homeostasis and late endosome function (55), 
whereas further studies are needed to elucidate the 
function of LC3/GABARAP conjugation to ATG3 
and its deconjugation by ATG4 proteases. Indeed, 
it may now be necessary to distinguish whether 
previously-studied phenotypes of ATG3 K243R 
(54, 55) occur as a consequence of impaired 
ATG12 or LC3/GABARAP conjugation. Notably, 
in our pulldown experiments we observed multiple 
species of LC3B-ATG3 conjugates at distinct 
molecular weight intervals corresponding to the 
size of 3xFLAG-LC3B, suggesting other ATG3 or 
LC3B residues may be modified. 
Multiple models of ATG4 KO yeast cells 
expressing pre-primed ATG8 have been generated 
and studied extensively in the context of ATG4 
delipidation (56–58). These could be utilized to 
study whether ATG4 has an evolutionarily 
conserved role in deconjugating ATG8 from 
proteins. Interestingly, yeast ATG8 can stably 
conjugate to ATG3 residue S4 in vitro (59), 
however this residue is not conserved in 
mammalian ATG3 (60). 
Finally, our study has described the rational 
development of a deconjugation-resistant LC3B 
mutant (Q116P G120). We expect this to be an 
important research tool for investigating roles of 
LC3B deconjugation in different contexts, given 
the emerging multifaceted functions of 
LC3/GABARAP proteins in pathways beyond 
canonical autophagy such as secretion (61) and 
LC3-associated phagocytosis (62). 
 
Experimental procedures 
Cell culture 
HeLa control, ATG4B KO, ATG4A/B DKO (clone 
25) cells and lines stably expressing GFP-LC3B 
constructs under control of the CMV or PGK 
promoter were generated and validated in a 
previous study (38). These were grown in DMEM 
high glucose with GlutaMax containing 1 mM 
pyruvate, supplemented with Penicillin-
Streptomycin (100 U/ml) and 10% FBS. HAP1 
control cells (Horizon Genomics, C631) and 
HAP1 ATG4B KO cells (Horizon Genomics, 
HZGHC001241c011) were grown in IMDM 
containing 25 mM HEPES and L-Glutamine 
supplemented with Penicillin-Streptomycin (100 
U/ml each) and 10% heat-inactivated FBS. All 
medium and supplements were purchased from 
ThermoFisher Scientific. Cells were maintained at 
37°C and 5% CO2. 
 
Plasmid transfection 
HeLa cells and lines grown in 12 well plate wells 
(seeded at a density of 1x104 cells per well) were 
transfected with 250 ng total plasmid DNA using 
1.5 µl jetPRIME reagent (Polyplus-transfection) 
and 50 µl jetPRIME buffer per well (containing 1 
ml of growth medium). Transfections were scaled 
up or down according to growth medium volume 
and cell densities were scaled according to well 
surface area. HAP1 cells were transfected using 
PEI as described previously (protease protection 
experiment) (38), or using Viromer Yellow 
(Lipocalyx GmbH) according to the 
manufacturer’s protocol (microscopy experiment). 
All experiments were performed 24 hours after 
transfection. 
 
CRISPR-Cas9 genome editing 
Sanger CRISPR Finder (63) was used to select a 
specific spCas9 target sequence with no predicted 
exonic off-target sites in exon 5 of human ATG3 
(location: chr3:112,548,624-112,548,646; CRISPR 
ID: 959983715). Complementary oligonucleotides 
incorporating the 19 bp target sequence adjacent to 
the PAM were designed and synthesized with 
cloning-compatible overhangs, consisting of: 
sgATG3(+) (5’-
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CACCGTATAGTGCCGTGCTATAAG-3’) and 
sgATG3(-) (5’-
AAACCTTATAGCACGGCACTATAC-3’). 
These oligos were annealed, phosphorylated and 
cloned into BbsI-digested pSpCas9(BB)-2A-Puro 
(PX459) V2.0, a gift from Feng Zhang (Addgene 
plasmid # 62988), as described (64). Wild-type 
HeLa cells were transfected with the resulting 
plasmid as described above for ‘plasmid 
transfection’, followed by 48 hour growth in the 
presence of 1 µg/ml puromycin. Surviving cells 
were then expanded into 10 cm dishes for 72 
hours, prior to seeding at limiting dilution in 96 
well plates. After 2 weeks, clonal cell lines were 
expanded into 12 well plates and screened for loss 
of ATG3 protein by western blotting. One verified 
HeLa ATG3 KO cell line (referred to as clone 31) 
was used for this study. 
 
Antibodies & reagents 
Primary antibodies and dilutions used for western 
blotting were as follows: ATG3 C-ter (1/1,000, 
Abcam, ab108282), ATG3 N-ter (1/1,000, Abcam, 
ab108251), ATG4B (1/1,000, Cell Signaling 
Technology, #5299), Beta-ACTIN (1/4,000, 
Sigma, A1978), FLAG biotin-conjugated (1/1,000, 
Sigma, F9291), GFP (1/2,000, Clontech, 632381), 
LC3A/B (1/500 Cell Signaling Technology, 
#12741), LC3B (1/1,000, Sigma, L7543), 
SQSTM1 (1/1,000, Sigma, P0057), VINCULIN 
(1/1,000, Abcam, ab129002). 
Secondary antibodies for western blotting with 
chemiluminescence-based detection: goat anti-
rabbit/anti-mouse IgG, HRP-linked (1/5,000, Cell 
Signaling Technology, #7074/#7076). For 
fluorescence-based detection: IRDye 800CW goat 
anti-rabbit/anti-mouse (1/15,000 with 0.02% SDS, 
LI-COR 926-32211/926-32212), IRDye 680LT 
goat anti-rabbit/anti-mouse (1/25,000 with 0.02% 
SDS, LI-COR 926-68021/926-68020). 
Torin1 was purchased from Merck-Millipore 
(475991) and bafilomycin A1 from Streptomyces 
griseus was purchased from Sigma (B1793); both 
were dissolved in DMSO. Recombinant GST-
ATG4B WT and C74S were produced and 
purified as described previously (65). Earle's 
Balanced Salt Solution (EBSS) containing calcium 
and magnesium was purchased from 
ThermoFisher (24010-043). 
 
Plasmids & cloning 
New mutations were introduced into the Gateway 
entry clones encoding LC3B WT and LC3B G120 
containing stop codons described previously (38). 
LC3B F80A+L82A was generated by overlap 
extension PCR. LC3B F119A was generated by 
conventional PCR using mutagenic reverse 
primers. The final product of each of these PCRs 
was purified and recombined with pDONR223 
using BP clonase II enzyme mix (Life 
Technologies) (66). LC3B Q116P and E117P were 
generated by site-directed mutagenesis using Q5 
Site-Directed Mutagenesis Kit (NEB) according to 
the manufacturer’s protocol. Primers used for PCR 
reactions are listed in Table S1. To generate 
LC3B mutant entry clones lacking stop codons, 
mutant LC3B coding sequences containing stop 
codons (detailed above) were PCR amplified using 
the common primers LC3B forward (5’- 
GGGGACAAGTTTGTACAAAAAAGCAGGCT
TAATGCCGTCGGAGAAGACC-3’) and LC3B 
WT reverse with no stop codon (5’- 
GGGGACCACTTTGTACAAGAAAGCTGGGT
ACACTGACAATTTCATCCCG-3’) prior to BP 
recombination of the PCR product with 
pDONR223.  
To generate an ATG3 entry clone encoding wild-
type ATG3 with a stop codon, the ATG3 CDS was 
PCR-amplified from pDONR223_ATG3_WT_V5 
(a gift from Jesse Boehm & Matthew Meyerson & 
David Root, Addgene plasmid # 82952 (67)) using 
the primers ATG3 forward (5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCT
TAATGCAGAATGTGATTAATACTGTG-3’) 
and ATG3 reverse with stop codon (5’- 
GGGGACCACTTTGTACAAGAAAGCTGGGT
ATTACATTGTGAAGTGTCTTGTGTAG-3’). 
The same primers were also used to amplify a 
custom synthetic dsDNA fragment (GeneStrands, 
Eurofins Genomics) encoding full-length ATG3 
CDS with all lysine residues converted to arginine 
(allKR), achieved by mutating all in-frame AAA 
or AAG codons to AGA or AGG, respectively. 
PCR products were purified prior to BP 
recombination with pDONR223 to generate entry 
clones. 
Tagged expression constructs of LC3B mutants 
and ATG3 wild-type/allKR were generated by 
recombining entry clones (above) with destination 
vectors described previously (38), using LR 
clonase II enzyme mix. For 3xFLAG-LC3B-GFP 
constructs, entry clones lacking stop codons were 
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recombined with pDEST-CMV-3xFLAG-
gateway-EGFP. To make GFP-LC3B constructs, 
entry clones with stop codons were recombined 
with pDEST-CMV-N-EGFP. For 3xFLAG-LC3B 
constructs and 3xFLAG-ATG3, entry clones 
containing stop codons were recombined with the 
destination vector pCMV-tripleFLAG-Gateway 
(68). Further individual mutations were introduced 
into 3xFLAG-ATG3 using mutagenic primers 
listed in Table S2 and Q5 Mutagenesis Kit, or an 
equivalent inverse PCR method employing 
Phusion polymerase, DpnI digestion of the PCR 
mixture, followed by co-treatment with T4 
Polynucleotide Kinase and T4 DNA ligase (all 
purchased from NEB). The hybrid 3xFLAG-
ATG3 wild-type/allKR constructs 3xFLAG-ATG3 
1-13KR and 14-22KR were generated by 
restriction-based cloning: 3xFLAG-ATG3 WT and 
3xFLAG-ATG3 allKR were both digested using 
KpnI + PstI, with the resulting insert fragments 
(containing the sequence encoding the first 13 
lysines or replaced arginines residues in ATG3) 
swapped between the two vectors. 3xFLAG-
LC3/GABARAP isoforms (G116, G120 or G126 
pre-primed versions) and negative control (LC3B 
G120A) were generated and described previously 
(38). As transfection controls, pEAK13-EGFP was 
used for expression of GFP alone (69), and pCMV 
SPORT6-mCherry was used for the expression of 
mCherry (52). Plasmids were validated by 
restriction enzyme digests and Sanger sequencing. 
 
Western blotting 
Cells were washed in cold PBS prior to lysis on 
ice using lysis buffer (150 mM NaCl, 1% IGEPAL 
CA-630, 50 mM Tris-HCl pH 8.0, Roche 
cOmplete™ EDTA-free Protease Inhibitor 
Cocktail) supplemented with 20 mM N-
Ethylmaleimide (unless otherwise stated) to inhibit 
ATG4 activity in lysates (38). Lysates were 
cleared by centrifugation at 15,000 x g at 4°C and 
the resulting pellet was discarded. Total protein 
concentrations were determined using Pierce BCA 
Protein Assay Kit (Thermo Scientific) and lysates 
were diluted to approximately equal 
concentrations before addition of 5X SDS sample 
buffer (250 mM Tris-Cl pH 6.8, 10 % SDS, 50% 
glycerol, 25% beta-mercaptoethanol and 0.05% 
bromophenol blue) with immediate boiling at 
95°C for 5 minutes. When comparing non-
reducing and reducing sample conditions, NEM 
was excluded from the lysis buffer and lysates 
were divided into two equal volumes prior to 
addition of 3X SDS sample buffer (150 mM Tris-
Cl pH 6.8, 6% SDS, 30% glycerol 15% beta-
mercaptoethanol and 0.03% bromophenol blue), 
with beta-mercaptoethanol added fresh for 
reducing sample buffer or substituted with distilled 
water for non-reducing sample buffer. Reduced 
samples were boiled as normal while non-reduced 
samples were kept at room temperature. Equal 
volumes of sample (typically 15-25 µg total 
protein) were loaded into lanes of a 15-well 4-20% 
Mini-PROTEAN TGX Precast Gel or 26-well 4-
20% Criterion TGX gel (Bio-Rad) and run at 115 
V constant for 75 minutes or 200 V for 35 
minutes. Protein was transferred to Immobilon-FL 
PVDF membrane (Merck-Millipore) before 
blocking with 5% skimmed milk in PBS-T (PBS 
with 0.05% Tween-20) for 1 hour. The membrane 
was probed with primary antibody in blocking 
buffer at room temperature for 1 hour (for FLAG, 
ACTIN or VINCULIN antibodies) or overnight at 
4°C (for all other antibodies). After washing with 
PBS-T, the membrane was incubated in secondary 
antibody in blocking buffer for 1 hour at room 
temperature. Washes were performed prior to 
image acquisition on an Odyssey infrared imaging 
system (LI-COR Biosciences) or development 
using HRP substrate (EZ-ECL chemiluminescence 
detection kit for HRP, Geneflow Ltd) followed by 
exposure on an ImageQuant chemilumenscent 
imaging system (GE Healthcare). ACTIN and 
VINCULIN were detected as loading controls. All 
experimental observations were confirmed in a 
minimum of three independent experiments. 
 
Cell fractionation and ATG4B protease 
protection assay 
HAP1 ATG4B KO cells grown in a 10 cm tissue 
culture dish were transfected with 10 µg of 
plasmid DNA encoding 3xFLAG-LC3B G120. 
The next day, cells were treated for 3 hours with 
250 nM Torin1 and 10 nM baf A1 to induce 
lipidation of 3xFLAG-LC3B G120. Intact cells 
were then collected as a pellet by trypsinization, 
trypsin inactivation in complete growth medium, 
and centrifugation at 300 x g for 5 minutes. The 
cell pellet was washed once in cold PBS before 
resuspending in 0.7 ml of homogenization buffer 
(HB) consisting of 10mM HEPES-KOH pH 7.5, 
0.22 M D-mannitol, 0.07 M sucrose and Roche 
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cOmplete™ EDTA-free Protease Inhibitor 
Cocktail. Cells were ruptured by passing the 
suspension ten times through a 27G needle 
attached to a 1 ml syringe. The resulting 
homogenate was centrifuged twice at 300 x g, 4°C, 
for 10 minutes, each time discarding the nuclear 
pellet. The post-nuclear supernatant was 
centrifuged at 15,200 x g, 4°C, for 10 minutes to 
generate a membrane-enriched low-speed pellet 
that was resuspended in 0.7 ml of HB, while the 
cytosol-enriched supernatant was transferred to a 
new tube. The two fractions were then further 
divided into non-permeabilized and permeabilized 
stocks by addition of 1/10 volume of HB or HB 
containing 5% Triton X-100. At this point, 1 M 
DTT was added to a final concentration of 4.5 
mM. These stocks were then subdivided into 
reaction tubes containing a final concentration of 
0.03 mg / ml GST-ATG4B or an equivalent 
volume of HB, and treated for 30 minutes at 37°C, 
with one untreated sample kept on ice as a control. 
To stop the reactions, all tubes were placed on ice 
and 5X SDS sample buffer was added prior to 
immediate boiling at 95°C for 10 minutes. Equal 
volumes of sample were loaded on polyacrylamide 
gels and analyzed by western blotting. 
 
Immunoprecipitation 
HeLa cell lines grown in 10 cm dishes were 
transfected with a total of 2.5 µg plasmid DNA. 
After 24 hours, cells were washed in cold PBS and 
lysed in approximately 1 ml of IP buffer (50 mM 
Tris-HCl pH 8, 150 mM NaCl, 1 mM EDTA, 1% 
Triton X-100 and Roche cOmplete™ EDTA-free 
Protease Inhibitor Cocktail). Lysates were cleared 
by centrifugation at 15,000 x g for 10 minutes at 
4°C. After 100 µl input sample was collected into 
a separate tube and boiled in sample buffer, the 
remaining cleared lysate was loaded onto ANTI-
FLAG® M2 Affinity Gel (A2220, Sigma) that had 
previously been equilibrated by washing three 
times with 1 ml IP buffer. Approximately 30 µl of 
packed gel was used per sample, and binding was 
performed at 4°C for 3 hours on a tube rotator. Gel 
was washed three times with 1 ml IP buffer and 
bound protein was eluted from the gel by 
incubating with 3xFLAG peptide (F4799, Sigma) 
at 150 ng/µl in IP buffer for 30 minutes at 4°C 
with shaking. Eluted sample (approx. 100 µl) was 
carefully removed from pelleted gel prior to 
digestion with recombinant GST-ATG4B and/or 
boiling in 5X SDS sample buffer to prepare 
samples for western blotting. 
 
Light microscopy 
Cells seeded on borosilicate glass coverslips 
(VWR, 13 mm diameter, thickness no. 1.5) were 
washed in PBS and fixed for 10 minutes at room 
temperature in 4% paraformaldehyde in PBS. The 
coverslips were then washed, stained with 1 µg/ml 
Hoechst 33342 for 10 minutes, washed and 
mounted onto glass slides using ProLong Diamond 
mounting medium (Life Technologies) and cured 
overnight at room temperature in the dark. Fixed 
cells were imaged on a Leica SP8 confocal laser 
scanning microscope using a 63x oil immersion 
objective with a numerical aperture (N.A.) of 1.4 
at 400 Hz with sequential channel acquisition. 
Laser and gain settings were optimized for the 
brightest sample to avoid signal saturation, and the 
same settings were used to image all samples 
within a single experiment. All images shown are 
of a single confocal Z-slice. 
 
Protein structure modelling and visualization 
The FASTA sequence for the ATG4B-LC3(1-124) 
(PDB ID: 2Z0E) complex was downloaded from 
PDB (Protein Data Bank). The LC3 residue Q116 
was mutated to proline and submitted to SWISS-
MODEL (70) for protein tertiary structure 
prediction using PDB:2Z0E as a template. PyMOL 
was used for model visualization, and reported an 
all atom RMSD (Root Mean Square Deviation) of 
0.058 Å between the mutated model and actual 
crystal structure. 
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Figure 1. Development of deconjugation-resistant LC3B mutant reveals novel LC3B conjugates in cells. 
(A) LC3B priming assay in HeLa cells using transiently transfected 3xFLAG-LC3B-GFP construct 
and point mutants. Western blotting of lysates using anti-FLAG antibody shown on left hand side 
(asterisk indicates non-specific cleavage product), schematic of construct processing by 
endogenous ATG4 in cells shown on right. 
(B) Confocal microscopy of GFP localization in HAP1 control cells transiently transfected with GFP-
LC3B constructs and treated with DMSO or 250 nM Torin1 + 10 nM baf A1 for 3 hours prior to 
fixation. Point mutations were introduced into pre-primed G120 form of GFP-LC3B where 
indicated. Scale bar: 10 µm. 
(C) Location of LC3B Q116 residue within binding pocket of ATG4B visualized using co-crystal 
structure PDB:2Z0E (42), with LC3B displayed as ribbon in yellow and ATG4B as surface model 
in green (left hand side). Boxes show close up of H-bond interactions between LC3B Q116 and 
ATG4B residue N146, I317 and L228 for WT (middle) and modelled Q116P mutation (right). 
(D) 3xFLAG-LC3B constructs (schematics shown on left) were transiently expressed in HeLa control 
cells prior to lysis and western blot detection using anti-FLAG antibody (right). 
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Figure 2. Identification and characterization of LC3/GABARAP conjugates in ATG4 deficient cells. 
(A) Expression of pre-primed 3xFLAG-tagged LC3/GABARAP isoforms (LC3A G120, LC3C G126, 
GABARAP G116, GABARAPL1 G116 and GABARAPL2 G116) and LC3B mutants in control, 
ATG4B KO and ATG4A/B double knockout (DKO) HeLa cells using transient transfection prior 
to western blot analysis. Panels are vertically divided for presentation; all results are from the 
same membrane and displayed at the same exposure. 
(B) Digestion of 3xFLAG-LC3B conjugates from HeLa ATG4B KO cells. Lysates were prepared in 
IP buffer and subsequently incubated on ice (untreated samples) or at 37°C for 1 hour with 
purified recombinant GST-ATG4B WT or inactive (C74S) mutant at a final concentration of 0.02 
mg/ml, prior to western blotting. ATG4B antibody was used to detect GST-ATG4B.  
(C) Assessment of GFP-LC3B conjugates following autophagy modulation. HeLa control and 
ATG4B KO cells stably expressing GFP-LC3B G120 were treated with combinations of EBSS, 
DMSO, 250 nM Torin1 and 10 nM baf for 3 hours prior to lysis and western blot analysis. 
Endogenous LC3B was detected using anti-LC3B antibody and GFP-LC3B conjugates were 
detected using anti-GFP. 
(D) Cell fractionation and GST-ATG4B protease protection assessment of 3xFLAG-LC3B 
conjugates. HAP1 ATG4B KO cells transiently transfected with 3xFLAG-LC3B G120 were 
treated for 3 hours with 250 nM Torin1 and 10 nM baf A1 prior to sample preparation, processing 
and analysis by western blotting (left). 3xFLAG-LC3B G120 was detected using anti-FLAG 
antibody and endogenous LC3B was detected using anti-LC3B (consisting of pro-LC3B in 
untreated samples). On right is a schematic highlighting how presence of detergent (Triton) 
disrupts protease protection as a positive control. 
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Figure 3. ATG3 protein is a target of LC3/GABARAP conjugation and ATG4-mediated deconjugation. 
(A) Enrichment of transiently expressed 3xFLAG-LC3B G120 from HeLa control and ATG4B KO 
cells by immunoprecipitation (IP) with anti-FLAG antibody prior to western blotting with anti-
FLAG antibody (left) and anti-ATG3 antibodies (middle, right panel). Cells were transfected with 
GFP as a negative control. 
(B) 3xFLAG-LC3B G120 expressed in HeLa ATG4B KO cells was enriched by IP with anti-FLAG 
antibody prior to treatment with 0.02 mg/ml recombinant GST-ATG4B WT or C74S at 37°C for 
1 hour and western blotting using anti-FLAG and anti-ATG3 N-ter antibody. 
(C) HeLa control and ATG4B KO cells were transfected with 3xFLAG-LC3B G120, 3xFLAG-LC3B 
Q116P G120, or GFP as a negative control prior to harvesting. Western blotting was performed to 
detect 3xFLAG-LC3B and ATG3 using the same lysates diluted with either non-reducing (β-
mercaptoethanol excluded) or reducing (standard recipe) sample buffer. Thioester-linked species 
are detected under non-reducing conditions only. 
(D) Western blotting of HeLa ATG4B KO GFP-LC3B G120 cells transiently transfected with 
3xFLAG-ATG3 WT and point mutant constructs. Samples were lysed in buffer lacking NEM and 
processed under reducing conditions (upper panel). The same constructs were used to rescue 
HeLa ATG3 KO cells treated for 3 hours with 250 nM Torin1 and 10 nM baf A1, assessed by 
western blotting under non-reducing conditions (lower panel). 
(E) Schematic of human ATG4 protease cellular function in protein deconjugation (‘deLC3ylation’), 
which counteracts covalent attachment of LC3/GABARAP (‘LC3ylation’) to ATG3 protein at 
residue K243. 
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